EV/EBITDA
-3.52
-0.47-15.41%
10 min ago
Summary
- As of February 7, 2025, DSGN EV/EBITDA is -3.52, with a fall of -0.47 (-15.41%) during the most recent trading day.
- Over the past year, DSGN EV/EBITDA has dropped by -2.10 (-147.89%).
- DSGN EV/EBITDA is now -238.46% below its all-time high of -1.04.
Performance
DSGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DSGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -15.4% | +15.1% | +13.1% |
| 1 m1 month | +31.0% | -31.1% | -28.6% |
| 3 m3 months | +29.3% | -29.4% | -26.9% |
| 6 m6 months | -17.7% | +12.6% | +3.7% |
| ytdytd | +34.1% | -34.2% | -31.4% |
| 1 y1 year | -147.9% | +91.4% | +85.5% |
| 5 y5 years | - | - | - |
DSGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -15.4% | -5.47 | +35.6% | |
| 3 m | 3-month | -3.05 | -15.4% | -6.60 | +46.7% |
| 6 m | 6-month | -2.98 | -18.1% | -6.60 | +46.7% |
| 1 y | 1-year | -1.42 | -147.9% | -6.60 | +46.7% |
| 3 y | 3-year | -1.04 | -238.5% | -26.14 | +86.5% |
| 5 y | 5-year | -1.04 | -238.5% | -219.57 | +98.4% |
| alltime | all time | -1.04 | -238.5% | -219.57 | +98.4% |
Design Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.52(-34.1%) |
| 2024 | -5.34(+216.0%) |
| Date | Value |
|---|---|
| 2023 | -1.69(-80.2%) |
| 2022 | -8.52(-65.9%) |
| 2021 | -24.99 |
FAQ
- What is Design Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Design Therapeutics?
- What is DSGN EV/EBITDA year-to-date change?
- What is Design Therapeutics EV/EBITDA year-on-year change?
What is Design Therapeutics EV/EBITDA?
The current EV/EBITDA of DSGN is -3.52
What is the all time high EV/EBITDA for Design Therapeutics?
Design Therapeutics all-time high EV/EBITDA is -1.04
What is DSGN EV/EBITDA year-to-date change?
Design Therapeutics EV/EBITDA has changed by +1.82 (+34.08%) since the beginning of the year
What is Design Therapeutics EV/EBITDA year-on-year change?
Over the past year, DSGN EV/EBITDA has changed by -2.10 (-147.89%)